Does BCG provide long-term protection against SARS-CoV-2 infection? A case–control study in Quebec, Canada

BACKGROUND: Early in the coronavirus disease 2019 (COVID-19) pandemic, before severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines became available, it was hypothesized that BCG (Bacillus Calmette–Guérin), which stimulates innate immunity, could provide protection against SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Pépin, Jacques, Labbé, Annie-Claude, Carignan, Alex, Parent, Marie-Elise, Yu, Jennifer, Grenier, Cynthia, Beauchemin, Stéphanie, De Wals, Philippe, Valiquette, Louis, Rousseau, Marie-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354805/
https://www.ncbi.nlm.nih.gov/pubmed/34493410
http://dx.doi.org/10.1016/j.vaccine.2021.08.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354805/
https://www.ncbi.nlm.nih.gov/pubmed/34493410
http://dx.doi.org/10.1016/j.vaccine.2021.08.019

Ejemplares similares